We are pleased to announce that our project has been selected for the Ministry of Economy, Trade and Industry (METI)’s “FY2026 Subsidy Program for the International Expansion of the Healthcare Industry,” administered by Medical Excellence JAPAN (MEJ).

https://medicalexcellencejapan.org/common/img/all/pdf/R8hojo_saitakulist.pdf

• Subsidy Program: FY2026 Subsidy Program for the International Expansion of the Healthcare Industry

• Selected Project: Basic Survey Project for the Commercialization of “NovaID,” an AI-Powered Healthcare Support Service for Antimicrobial Resistance (AMR) in East Africa (Rwanda and Kenya)

• Target Region: East Africa (Rwanda and Kenya)

• Managing Organization: Medical Excellence JAPAN (MEJ)

Through this study, we will promote the commercialization and local deployment of “NovaID,” an AI-powered healthcare support service, to help address antimicrobial resistance (AMR) challenges in Rwanda and Kenya.